ALKBH5 deficiency decreased PD‐L1 protein level by suppressing ZDHHC3 mRNA expression in an m6A modification manner, further enhancing the efficacy of anti‐PD‐1 therapy for GBM.40 This evidence concerns the gene ALKBH5 and glioblastoma.